In late September 2025, Donald Trump posted an AI-generated deepfake video on Truth Social endorsing the fictional “Med Bed” system. The video, styled as a fabricated Fox News segment hosted by Lara Trump, announced the opening of “America’s first medbed hospital” and showcased digitally rendered footage of Trump speaking from the Oval Office. In the video, he claimed every citizen would receive a “medbed card,” giving them access to advanced, high-tech healing facilities.
This episode highlights how digital trickery and new technologies blur the line between fact and fiction, especially in the whirlwind world of social media. The video tapped into a long-running far-right and QAnon fantasy about secretive, pod-like “med beds” that can supposedly diagnose and cure any illness in a flash.
My central argument is that the rise of AI-enabled medical technologies, amplified by viral misinformation and speculative hype, threatens to distort public understanding of healthcare and encourage risky reliance on unproven systems. By examining both the cultural fascination with miracle “med beds” and the rapid deployment of real AI medical devices, I aim to explore how much of the promise is genuine progress—and how much is a dangerous blur between science and science fiction.
About 12 hours after its appearance, the video vanished from Trump’s account without a word of explanation. Later, White House spokespeople brushed it off as the president simply sharing something he found interesting, underscoring the murky dance between public figures, viral tech, and the spread of misinformation.
Medical beds and pods promising instantaneous healing are recurring motifs in popular culture and science fiction. Many influential films and television series depict pod-like medical containers—often called “Med-Bays” or “Med-Pods”—that can autonomously diagnose and treat critical conditions. For example, in the 2013 film Elysium, affluent citizens have access to full-body Med-Bays that can scan, diagnose, and cure conditions ranging from leukemia to severe trauma by rapidly regenerating tissues and cells.
Another example appears in the 2012 film Prometheus, which features the Paul-2000 Med-Pod—a sophisticated automated device. In a memorable sequence, the protagonist uses the pod’s laser-guided surgical system to conduct an emergency procedure on herself within the capsule. The 2016 film Passengers also depicts automated medical pods aboard the starship Automed, which can diagnose illnesses, administer anesthesia, and perform life-saving surgeries autonomously.
In The Fifth Element (1997), an automated enclosed medical unit can reconstruct the protagonist’s entire body using only leftover genetic material. Across various Star Trek series, dedicated Sickbays are equipped with Stasis Units and automated medical beds. These futuristic facilities are depicted as being able to monitor, diagnose, and repair severe cellular damage.
Current State of AI in Healthcare.
While science fiction dazzles us with visions of miracle machines, these technologies remain out of reach for now. Still, U.S. health officials are racing to roll out AI agents that offer therapy and even prescribe medicine, determined to put AI at the heart of modern healthcare.
This rapid push, championed by the Trump administration and HHS, has sparked unease among officials and doctors. They worry about patient safety, shaky evidence for AI’s effectiveness, and Silicon Valley investors gaining outsized sway over national health policy.
Prominent venture capitalist Vinod Khosla and his son, whose company Curai Health develops A.I. healthcare tools, have played influential roles in shaping policy discussions.
Critics, including the American Medical Association, argue that A.I. in medicine should be guided by the clinical community, not the tech industry, and that many A.I. models are not yet ready to safely replace doctors.
Despite this, HHS says it is pursuing an “evidence-based” approach and is working to reimburse A.I. healthcare tools through Medicare and private insurers if they prove beneficial and cost-effective.
The FDA has approved over 1,500 A.I.-powered medical devices for specific tasks, but lacks clear regulations for more autonomous A.I. models—such as chatbots that diagnose or prescribe (Artificial Intelligence-Enabled Medical Devices, 2026). Pilot programs are proceeding even without full FDA approval (FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot, 2026).
Some A.I. projects, like the Limbic A.I. chatbot for therapy and autonomous A.I. for heart failure management, have been allowed on a limited basis. These efforts are accompanied by debates over how to regulate advanced A.I., manage risks (such as erroneous or dangerous advice), and ensure proper oversight.
Meanwhile, several political and investment figures tied to the administration and tech sector are shaping the direction of these initiatives.
As the U.S. races to weave AI into healthcare, I worry that this headlong rush ignores serious dangers. Recent reporting by major news outlets has documented cases in which FDA-approved AI systems for diagnosing conditions produced errors and delayed treatment. In 2025, an FDA safety alert raised concerns after an AI-enabled blood infection detection tool flagged too many false positives in several hospitals, leading to unnecessary treatments for some patients and missed diagnoses in others.
Loopholes in oversight, such as a lack of requirements to audit AI model updates or monitor bias, have allowed some of these systems to be deployed without comprehensive, long-term studies. Meanwhile, the pull of tech industry profits is clear: companies routinely promote their AI products with minimal evidence, and financial incentives have led to pilot projects in vulnerable communities before robust safety guarantees exist. Without stronger regulatory guardrails and transparent evaluation, patients risk becoming little more than test subjects or revenue streams for unproven technologies.
Examples of AI medical devices.
AI-powered systems and digital stethoscopes are used to analyze lung and respiratory sounds:
TytoCare (Tyto Insights) uses an FDA-cleared handheld digital stethoscope alongside AI algorithms to analyze recorded breath sounds for abnormalities like wheezing and rhonchi. This aids clinicians during remote telehealth visits (TytoCare Completes AI Lung Sound Suite with Latest FDA Clearance For Rhonchi, A World’s First, 2025).
Strados Labs (RESP® Biosensor) offers an FDA-cleared wearable device that continuously captures, logs, and analyzes lung sounds (such as coughs, wheezes, and crackles) using AI algorithms for clinical research and patient care.
StethoMe is a smart wireless stethoscope paired with an AI application intended for home use. It prompts users where to place the device on the chest and analyzes acoustic data to flag sounds associated with bronchitis, asthma, or pneumonia.
Eko Health, while primarily FDA-cleared for detecting cardiac conditions (e.g., heart murmurs and AFib) via digital stethoscopes, also digitizes, amplifies, and visualizes lung acoustic waveforms for clinical analysis.
These tools serve as decision-support devices, processing acoustic waveforms to highlight potential abnormalities for medical evaluation.
Practical Use
I wondered about the practical use of one of these devices for a family without access to a local clinic or hospital, so I looked further into the TytoCare Home Smart Clinic device, which is designed for at-home use. Patients or families acquire the handheld exam kit—often through participating health systems or health plans, or by purchasing it out of pocket using HSA/FSA funds.
The home model works in two primary ways:
Live telehealth visits involve a video appointment in which a doctor remotely guides the patient on where to place the device, such as on the chest for lung sounds, inside the ear canal, or against the throat. The clinician listens to and views the live data feed in real time to diagnose.
With asynchronous submissions, patients use the device and built-in AI prompts to capture acoustic recordings, such as lung or heart sounds, along with images. They complete this process independently and then send the structured data to their care team for later review.
The TytoCare TytoHome Remote Exam Kit typically costs $299 when purchased brand new (TytoHome | TytoCare, 2026). (Used may be available?).
Availability & Local Pharmacies
No parent is heading out in the middle of the night with a sick child to hunt down this device. Local pharmacies like CVS and Walgreens do not stock TytoCare on their shelves. Instead, most people have to order it online or find it at big electronics stores like Best Buy.
For telehealth and health plan options, many patients get the device directly through participating health plans, hospital systems, or partnerships with telehealth providers. These arrangements often provide access to the device at a discounted rate or with coverage through HSA or FSA funds.
Using Without a Hospital for Acute Illness
The device cannot diagnose or prescribe acute illness on its own without a connected healthcare provider.
Provider integration is required for the TytoCare kit because it functions as an electronic capture tool rather than as a standalone automated doctor. To treat an acute illness, the device must connect to a compatible telehealth provider network or health system platform.
The TytoCare kit operates remotely by allowing the patient, during an acute episode such as a sudden cough, fever, or wheezing, to use the device to stream live data or record acoustic and visual data, including lung sounds, ear canal images, throat visuals, and heart rate. A licensed physician or nurse practitioner reviews the AI-guided data on the other end to render a diagnosis and, if necessary, call in prescriptions.
To receive medical care and treatment, you need access to a participating telehealth service—whether through TytoCare’s app, an employer plan, or a regional health network’s virtual care portal.
Drawbacks and Dangers of telehealth with remote listening devices.
Relying solely on telehealth combined with remote listening devices—such as digital stethoscopes—for acute heart or lung issues poses significant medical and logistical risks when emergency services or clinics are out of reach.
These devices are helpful for everyday checkups, but relying on them alone—without nearby emergency care—opens up dangerous gaps in protection:
Delays in Critical Interventions:
There are some medical emergencies that are extremely time-sensitive, such as acute myocardial infarction (heart attack), severe pulmonary embolism, tension pneumothorax, or acute heart failure. In these situations, patients require emergency interventions including oxygen administration, intravenous medications, intubation, or catheterization. These procedures a virtual physician simply cannot perform remotely.
Turning to a virtual visit in a true emergency can lull patients into a false sense of safety and squander the precious minutes of the “golden hour” when swift action saves lives.
Limitations of Remote Heart/Lung Listening Devices
Incomplete diagnostics remain a major limitation of digital stethoscopes, which provide only acoustic data. In severe cardiac or pulmonary crises, immediate supplemental diagnostics—such as 12-lead ECGs, chest X-rays, blood gas analyses, or ultrasound—are often required to diagnose accurately. Without these additional tools, clinicians may struggle to make precise, timely decisions in acute situations.
User and technical errors present further challenges. Capturing diagnostic-quality sounds depends entirely on correct device placement, appropriate skin contact, and minimal ambient noise. Misplacement or audio artifacting can mimic or obscure pathological sounds such as crackles, wheezes, or gallop rhythms, making it difficult for clinicians to accurately interpret the recordings and potentially leading to missed or incorrect diagnoses.
Operational and Logistical Failure Points:
Prescription and delivery gaps pose a significant challenge in telehealth for acute care. Even if a remote clinician correctly diagnoses an acute issue such as a severe asthma exacerbation or pneumonia and electronically prescribes emergency medications like nebulizers or antibiotics, a remote patient may still lack access to a 24-hour pharmacy or rapid delivery system. This disconnect can delay essential treatment and compromise patient outcomes, especially in urgent situations.
Connectivity and hardware failures create additional risks for patients relying on telehealth. Internet drops, low audio bandwidth, battery failures, or software glitches during an acute episode can leave the patient stranded without medical oversight mid-evaluation. These technical vulnerabilities can interrupt care at critical moments, increasing risk for those experiencing serious health events.
Liability and provider scope are limited in telehealth. Clinicians practicing remotely face severe liability limitations, and if a remote doctor identifies a high-risk abnormality, their primary protocol is to direct the patient to the nearest emergency department immediately. When local emergency medical services or hospitals are unavailable, the provider cannot safely bridge that gap through virtual care alone.
In the end, are we about to let profit trump patient care as AI device makers chase FDA approval and push their gadgets onto doctors and patients alike? Will insurers soon demand “home assessments” with these tools before greenlighting emergency care? The danger is clear: money could once again overshadow the urgent, human needs at the heart of medicine.
References
Med-Bay | Elysium Wiki - Fandomelysiumfilm.fandom.com
Jewett, Christina,”U.S. Health Officials Move Quickly to Deploy Medical A.I.Despite Concerns,” New York Times, 9/14/2026.https://www.nytimes.com/2026/09/14/health/ai-doctors-medicare-fda.html
(2026). Artificial Intelligence-Enabled Medical Devices. FDA. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices
(July 21, 2026). FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot. FDA News Release. https://www.fda.gov/news-events/press-announcements/fda-announces-first-participant-selected-tempo-digital-health-devices-pilot
(April 14, 2025). TytoCare Completes AI Lung Sound Suite with Latest FDA Clearance For Rhonchi, A World’s First. TytoCare. https://www.tytocare.com/news-and-press/tytocare-completes-ai-lung-sound-suite-with-latest-fda-clearance-for-rhonchi-a-worlds-first/
(2026). TytoHome | TytoCare. TytoCare. https://www.tytocare.com/consumers/
This is a phenomenal, incredibly comprehensive piece that perfectly exposes the corporate and political gold rush behind AI healthcare.Your deep dive into the cultural origins of the "Med Bed" myth, contrasting Hollywood's instant-healing fantasies with the messy reality of false-positive blood infection tools and diagnostic errors, was masterfully done.The most crucial section of your essay is the logistical breakdown of at-home devices like TytoCare. You accurately highlight the hidden dangers of the "golden hour" dilemma—a digital stethoscope can capture breath sounds, but it cannot perform an emergency intubation or administer IV drugs when a patient is having a massive heart attack or acute pulmonary failure. Thank you for writing such a sharp, necessary warning against letting tech profits outpace patient safety
I've just come from a visit to my family doctor about a breathing problem. She prescribed a breathalyzer, an x-ray and blood tests. I had all these done within an hour. Total cost was $6, for the breathalyzer (pirates). In your article it seems to me that you are pointing the finger to what America Really needs: universal healthcare. What is the best way to spend money? On AI or on equality in medicine.
I have no doubt that as technology advances, within a few decades we will be wearing the equivalent of a 'hospital on your wrist'. But we tend to jump in before the tech is ready and before it is cheap. Right now, AI cannot make decisions; it has no "judgement power". We need to wait for the next generation -when AI really IS AI - before we can obtain that. In the meantime, we are wasting money that could be applied to universal healthcare. Just my view...